On this page:OverviewKey papers
ScholarIQanswers from OpenAlex

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

JournalCitation impact & published research

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is a journal indexed in ScholarIQ from OpenAlex.

How many works does Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration have?

ScholarIQindexed works

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration has 1,605 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration have?

ScholarIQcitation count

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration has 30,847 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

ScholarIQh-index

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration has an h-index of 74 in OpenAlex.

What is the OpenAlex record for Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

ScholarIQopenalex

The OpenAlex for Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration is on the source record.

What are the most-cited papers on Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration?

ScholarIQmost cited works
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
Michael J. Strong, Sharon Abrahams, Laura H. Goldstein, Susan Woolley, Paula McLaughlin, Julie S. Snowden, Eneida Mioshi, Angela Roberts, Michael Benatar, Tibor Hortobágyi, Jeffrey Rosenfeld, Vincenzo Silani, Paul G. Ince, Martin R. Turner
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2017926 CitationsOPEN ACCESS
A revision of the El Escorial criteria - 2015
Albert C. Ludolph, Vivian E. Drory, Orla Hardiman, Imaharu Nakano, John Ravits, Wim Robberecht, Jeremy M. Shefner, for The WFN Research Group On ALS/MND
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2015480 Citations
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial
Jesús S. Mora, Angela Genge, Adriano Chiò, Conrado J. Estol, Delia Chaverri, Mariluz Hernández, Saúl Marín, Javier Mascías, Gabriel Rodríguez, Mónica Povedano, Andrés Paipa, Raúl Domínguez, Josep Gámez, María Salvadó, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean‐Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield, Olivier Hermine, on behalf of the AB10015 STUDY GROUP
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 2019222 CitationsOPEN ACCESS
The Swedish motor neuron disease quality registry
Elisa Longinetti, Amanda Regodón Wallin, Kristin Samuelsson, Rayomand Press, Anne Zachau, Lars‐Olof Ronnevi, Marie Kierkegaard, Peter M. Andersen, Jan Hillert, Fang Fang, Caroline Ingre
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 201894 Citations
Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls
Vicki Hertzberg, Harinder Singh, Christina Fournier, Ahmed Moustafa, Meraida Polak, Claire Kuelbs, Manolito Torralba, Malú G. Tansey, Karen E. Nelson, Jonathan D. Glass
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 202175 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial